Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Christoph Röllig(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), Christian Thiede(University Hospital Carl Gustav Carus), Michael Krämer(University Hospital Carl Gustav Carus), Frank Heits(Agaplesion Diakonieklinikum Rotenburg), Hermann Einsele(Universitätsklinikum Würzburg), Gerhard Ehninger(University Hospital Carl Gustav Carus), Norbert Frickhofen(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Markus Schaich(Rems-Murr-Klinikum), Sebastian Scholl(Jena University Hospital), Alexander Kiani(Bayreuth Medical Center), Wolfgang E. Berdel(University Hospital Münster), Björn Steffen(Goethe University Frankfurt), Carsten Müller‐Tidow(Heidelberg University), Claudia D. Baldus(University Hospital Schleswig-Holstein), Andreas Hochhaus(Jena University Hospital), Jan Moritz Middeke(Fresenius (Germany)), Dirk Niemann(Gemeinschaftsklinikum Mittelrhein), Tim H. Brümmendorf(National University Cancer Institute, Singapore), Johannes Kullmer(DIAKO), Andreas Neubauer(RWTH Aachen University), Friedrich Stölzel(German Cancer Research Center), Edgar Jost(Universitätsklinikum Aachen), Regina Herbst(Klinikum Chemnitz), Kristina Sohlbach(Philipps University of Marburg), Mathias Hänel(Klinikum Chemnitz), Ulrich Krümpelmann(Klinikum Bielefeld), Lars Fransecky, Volker Kunzmann(University of Würzburg), Christoph Schliemann(University Hospital Münster), Ulrich Kaiser(University of Applied Sciences Landshut), Uwe Platzbecker(National Center for Tumor Diseases), Stefan W. Krause(Universitätsklinikum Erlangen), Richard Noppeney(Essen University Hospital), Maxi Wass(University Hospital in Halle), Hubert Serve(Goethe University Frankfurt), Martin Kaufmann(Robert Bosch Hospital), Malte von Bonin(Städtisches Klinikum Dresden), Kerstin Schäfer‐Eckart(Nuremberg Hospital), Jan‐Henrik Mikesch(University Hospital Münster), Alwin Krämer(Heidelberg University), Johannes Schetelig(University Hospital Carl Gustav Carus)
Cited by 137
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k